U.S. Markets closed

Investor Expectations to Drive Momentum within Quaker Chemical, Ocular Therapeutix, Viad, Ingredion, LivePerson, and Tableau Software — Discovering Underlying Factors of Influence

NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quaker Chemical Corporation (KWR), Ocular Therapeutix, Inc. (OCUL), Viad Corp (VVI), Ingredion Incorporated (INGR), LivePerson, Inc. (LPSN), and Tableau Software, Inc. (DATA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

KWR DOWNLOAD: http://Fundamental-Markets.com/register/?so=KWR
OCUL DOWNLOAD:
http://Fundamental-Markets.com/register/?so=OCUL
VVI DOWNLOAD:
http://Fundamental-Markets.com/register/?so=VVI
INGR DOWNLOAD:
http://Fundamental-Markets.com/register/?so=INGR
LPSN DOWNLOAD:
http://Fundamental-Markets.com/register/?so=LPSN
DATA DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DATA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Quaker Chemical Corporation (KWR), Ocular Therapeutix, Inc. (OCUL), Viad Corp (VVI), Ingredion Incorporated (INGR), LivePerson, Inc. (LPSN), and Tableau Software, Inc. (DATA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed May 1st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

QUAKER CHEMICAL CORPORATION (KWR) REPORT OVERVIEW

Quaker Chemical's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Quaker Chemical reported revenue of $211.07MM vs $191.25MM (up 10.37%) and basic earnings per share -$0.74 vs $1.32. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Quaker Chemical reported revenue of $820.08MM vs $746.67MM (up 9.83%) and basic earnings per share $1.53 vs $4.64 (down 67.03%). Quaker Chemical is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.24. The estimated EPS forecast for the next fiscal year is $6.74 and is expected to report on February 27th, 2019.

To read the full Quaker Chemical Corporation (KWR) report, download it here: http://Fundamental-Markets.com/register/?so=KWR

-----------------------------------------

OCULAR THERAPEUTIX, INC. (OCUL) REPORT OVERVIEW

Ocular Therapeutix's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Ocular Therapeutix reported revenue of $0.49MM vs $0.51MM (down 4.70%) and basic earnings per share -$0.44 vs -$0.51. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ocular Therapeutix reported revenue of $1.92MM vs $1.89MM (up 1.91%) and basic earnings per share -$2.20 vs -$1.80. Ocular Therapeutix is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.58. The estimated EPS forecast for the next fiscal year is -$2.04 and is expected to report on March 14th, 2019.

To read the full Ocular Therapeutix, Inc. (OCUL) report, download it here: http://Fundamental-Markets.com/register/?so=OCUL

-----------------------------------------

VIAD CORP (VVI) REPORT OVERVIEW

Viad's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Viad reported revenue of $277.29MM vs $256.40MM (up 8.15%) and basic earnings per share -$1.06 vs -$0.19. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Viad reported revenue of $1,306.97MM vs $1,204.97MM (up 8.46%) and basic earnings per share $2.83 vs $2.09 (up 35.41%). Viad is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.22. The estimated EPS forecast for the next fiscal year is $3.01 and is expected to report on February 14th, 2019.

To read the full Viad Corp (VVI) report, download it here: http://Fundamental-Markets.com/register/?so=VVI

-----------------------------------------

INGREDION INCORPORATED (INGR) REPORT OVERVIEW

Ingredion's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Ingredion reported revenue of $1,437.00MM vs $1,400.00MM (up 2.64%) and basic earnings per share $1.37 vs $1.29 (up 6.20%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ingredion reported revenue of $5,832.00MM vs $5,704.00MM (up 2.24%) and basic earnings per share $7.21 vs $6.70 (up 7.61%). Ingredion is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.88. The estimated EPS forecast for the next fiscal year is $9.00 and is expected to report on February 7th, 2019.

To read the full Ingredion Incorporated (INGR) report, download it here: http://Fundamental-Markets.com/register/?so=INGR

-----------------------------------------

LIVEPERSON, INC. (LPSN) REPORT OVERVIEW

LivePerson's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, LivePerson reported revenue of $57.39MM vs $56.12MM (up 2.27%) and basic earnings per share -$0.07 vs -$0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, LivePerson reported revenue of $218.88MM vs $222.78MM (down 1.75%) and basic earnings per share -$0.32 vs -$0.46. LivePerson is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast for the next fiscal year is $0.00 and is expected to report on February 19th, 2019.

To read the full LivePerson, Inc. (LPSN) report, download it here: http://Fundamental-Markets.com/register/?so=LPSN

-----------------------------------------

TABLEAU SOFTWARE, INC. (DATA) REPORT OVERVIEW

Tableau Software's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Tableau Software reported revenue of $249.36MM vs $250.65MM (down 0.52%) and basic earnings per share -$0.51 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Tableau Software reported revenue of $877.06MM vs $826.94MM (up 6.06%) and basic earnings per share -$2.35 vs -$1.92.

To read the full Tableau Software, Inc. (DATA) report, download it here: http://Fundamental-Markets.com/register/?so=DATA

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com 

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.